Results 211 to 220 of about 59,410 (289)

How Safe Are Biological Agents in Pediatric Rheumatology? [PDF]

Turk Arch Pediatr
Nur Sunar Yayla E, Yıldız Ç, Esmeray Şenol P, Karaçayır N, Gezgin Yıldırım D, Bakkaloğlu SA.   +5 more
europepmc   +1 more source

Acute Intermittent Porphyria Triggered by COVID‐19 Mimicking Guillain–Barré Syndrome: A Diagnostic Challenge

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Acute intermittent porphyria (AIP) is a rare heme biosynthesis disorder in which the accumulation of neurotoxic porphyrin precursors precipitates neurovisceral attacks. Intercurrent infections, including coronavirus disease 2019 (COVID‐19), may trigger or exacerbate AIP and complicate diagnosis, as clinical manifestations can resemble those of
Payman Sadeghi, Masood Ghahvechi Akbari, Seyed Abbas Hassani, Hosein Alimadadi, Morteza Heidari, Vahid Ziaee   +5 more
wiley   +1 more source

Shaping the future of pediatric rheumatology. [PDF]

Pediatr Rheumatol Online J
Avčin T, Ravelli A.
europepmc   +1 more source

Application of Digital, Web‐Based, and Online Strategies in Point of Care Ultrasound (POCUS) Training: A Scoping Review

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Ultrasound is a commonly used modality in healthcare. Point of care ultrasound (POCUS) is performed at the patient's bedside with many purported benefits. Aims Given its increasingly popularity, this scoping review examined the role of digital, web‐based, and online educational strategies for POCUS. Methods Adhering to Joanna Briggs
Jessica Hang, Sandhya Maranna, Nayana Parange, Saravana Kumar   +3 more
wiley   +1 more source

The emerging paradigm in pediatric rheumatology: harnessing the power of artificial intelligence. [PDF]

Rheumatol Int
Koker O, Sahin S, Yildiz M, Adrovic A, Kasapcopur O.   +4 more
europepmc   +1 more source

The Current Use and Future Perspectives of Biosimilars in Pediatric Healthcare: A Narrative Review

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims The integration of biosimilars into pediatric healthcare represents a significant evolution in treatment accessibility and cost‐effectiveness. Biosimilars—biological products highly similar to already approved biologics, have emerged as promising alternatives for managing chronic and rare pediatric conditions, including ...
Zubaier Ahmed, Tasfiah Tasnim Maha, Sanjana Nowsher, Wasima Taslim, Fatema‐Tuz‐Zohora, Sabrina Sharmin, Hasina Yasmin   +6 more
wiley   +1 more source

Club Activity, Study Groups, and Academic Achievement: A Nationwide Study of Japanese Medical Students' Extracurricular Life

Journal of General and Family Medicine, Volume 27, Issue 3, May 2026.
ABSTRACT Background Student involvement in extracurricular activities (ECAs) possesses multiple benefits and has attracted substantial interest in medical education. Most studies on ECAs have been conducted in Western contexts, and findings on the association between ECAs and academic achievement are mixed.
Hirohisa Fujikawa, Hidetaka Tamune, Yuji Nishizaki, Hirotake Mori, Sho Fukui, Kiyoshi Shikino, Taro Shimizu, Yu Yamamoto, Hiroyuki Kobayashi, Toshio Naito, Yasuharu Tokuda   +10 more
wiley   +1 more source

Increasing and maintaining rates of standardized depression screening in youth with childhood-onset systemic lupus erythematosus in a pediatric rheumatology clinic. [PDF]

Pediatr Rheumatol Online J
Datyner E, Dingle J, Newsome V, Buckley LH, Belsky N, Park S, Mitchell M, Fine B, Patterson B, Graham TB, Davis A.   +10 more
europepmc   +1 more source

Long‐Term Safety and Efficacy of Pegvaliase in Japanese Adults With Phenylketonuria: Final Results of a Phase III Trial

JIMD Reports, Volume 67, Issue 3, May 2026.
ABSTRACT Phenylketonuria (PKU) is an inborn error of metabolism leading to phenylalanine (Phe) accumulation and consequent neurological, neurocognitive, and psychiatric symptoms. Pegvaliase, a pegylated recombinant phenylalanine ammonia lyase that metabolizes Phe, effectively reduced blood Phe in phase III studies in the United States. This multicenter,
Yoko Nakajima, Mika Ishige, Tetsuya Ito, Takashi Hamazaki, Mitsuhiro Kuwahara, Lawrence Lee, Haruo Shintaku   +6 more
wiley   +1 more source

Electronic health record modification and dashboard development to improve clinical care in pediatric rheumatology. [PDF]

Front Pediatr
Timmerman L, Dutton H, McDannald N, Smitherman EA, Mannion ML.   +4 more
europepmc   +1 more source